These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25023576)

  • 21. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole: therapy of choice in intellectually disabled children.
    Böhmer CJ; Niezen-de Boer RC; Klinkenberg-Knol EC; Meuwissen SG
    Arch Pediatr Adolesc Med; 1998 Nov; 152(11):1113-8. PubMed ID: 9811290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pantoprazole in older patients with erosive esophagitis.
    DeVault KR; Morgenstern DM; Lynn RB; Metz DC
    Dis Esophagus; 2007; 20(5):411-5. PubMed ID: 17760655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.
    Caos A; Moskovitz M; Dayal Y; Perdomo C; Niecestro R; Barth J
    Am J Gastroenterol; 2000 Nov; 95(11):3081-8. PubMed ID: 11095321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
    Heyman MB; Zhang W; Huang B; Chiu YL; Amer F; Winter HS
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):35-40. PubMed ID: 17204950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment.
    Vakil NB; Traxler B; Levine D
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):665-8. PubMed ID: 15290658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S
    Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Dutch Esophagitis Study Group.
    Wesdorp IC; Dekker W; Festen HP
    Clin Ther; 1997; 19(5):1048-57. PubMed ID: 9385492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reflux oesophagitis in children; the role of endoscopy. A multicentric Italian survey.
    Lombardi G; de' Angelis G; Rutigliano V; Guariso G; Romano C; Falchetti D; Pittschieler K; Brunero M; Lerro P; Sabbi T; Pepe G; De Venuto D; Torroni F; Bizzarri B; Di Nicola M; Di Mascio R; Dall'Oglio L
    Dig Liver Dis; 2007 Sep; 39(9):864-71. PubMed ID: 17681873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of Carlsson's questionnaire to predict erosive GERD among healthy Chinese.
    Hung CS; Lee CL; Yang JN; Liao PT; Tu TC; Chen TK; Wu CH
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1900-5. PubMed ID: 16336451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.
    Lauritsen K; Devière J; Bigard MA; Bayerdörffer E; Mózsik G; Murray F; Kristjánsdóttir S; Savarino V; Vetvik K; De Freitas D; Orive V; Rodrigo L; Fried M; Morris J; Schneider H; Eklund S; Larkö A
    Aliment Pharmacol Ther; 2003 Feb; 17 Suppl 1():24; discussion 25-7. PubMed ID: 12614304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors for response to treatment and recurrence of uncomplicated symptomatic gastroesophageal reflux in ambulatory care medicine].
    Bommelaer G; Caekaert A; Barthelemy P
    Presse Med; 2002 Sep; 31(30):1402-6. PubMed ID: 12378973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study.
    Ronkainen J; Talley NJ; Storskrubb T; Johansson SE; Lind T; Vieth M; Agréus L; Aro P
    Am J Gastroenterol; 2011 Nov; 106(11):1946-52. PubMed ID: 21946284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    BMC Pediatr; 2010 Jun; 10():41. PubMed ID: 20540767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.